Marcelo Cheresky, Mba Email & Phone Number
@canbridgepharma.com
2 phones found area 617
LinkedIn matched
Who is Marcelo Cheresky, Mba? Overview
A concise factual answer block for searchers comparing this professional profile.
Marcelo Cheresky, Mba is listed as Chief Executive Officer at KiteGene, based in Greater Boston, United States, United States. AeroLeads shows a work email signal at canbridgepharma.com, phone signal with area code 617, and a matched LinkedIn profile for Marcelo Cheresky, Mba.
Marcelo Cheresky, Mba previously worked as Independent Consultant at Self Employed and Chief Commercial Officer (CCO) at Canbridge Pharmaceuticals Inc.. Marcelo Cheresky, Mba holds Master Of Business Administration - Mba, Business Administration And Management, General from University Of North Carolina At Chapel Hill.
Email format at KiteGene
This section adds company-level context without repeating Marcelo Cheresky, Mba's masked contact details.
AeroLeads found 2 current-domain work email signals for Marcelo Cheresky, Mba. Compare company email patterns before reaching out.
About Marcelo Cheresky, Mba
Executive that leads global strategy, business development, markets, commercial, product launch, licensing, deal negotiation, P&L, and matrix cross-functional teams to achieve goals. Innovative thinker with deep gene therapy, rare disease, and biotechnology industry acumen. Demonstrates success in developing and executing plans in complex global, fast-paced, regulated environments. Creates and implements impactful strategies by analyzing details to understand competitors, trends, regulations, and partner relationships. Converts chaos to performance and complicated topics into simple concepts. Organized, creative problem-solver who excels at guiding teams through challenging emerging markets. Expertise managing $300M budgets and improving global, regional, and country-level growth. Shares contrarian perspectives when advising C-level executives and boards of directors.Accomplishments:• 24 years of leadership at CANbridge, Bioverativ (Sanofi), Genzyme, Eli Lilly, • Oversee global gene therapy and rare disease early development to commercial stage go-to-market planning, marketing, sales, contracts, negotiations, P&L, finance, regulatory, access, research partners, forecasts, metrics, reports, and 42 staff.• Bought license rights from 7 companies to develop and commercialize rare disease, gene therapy, and oncology products.• Launched new products, managed early and mature stage businesses, orphan drugs.• Led turnaround in the Mexican Genzyme affiliate that was experiencing declining revenue.• MBA, University of North CarolinaExpertise:• Strategic Planning • Product Launch • Commercial & Business Development • Global Market Access • Alliance Management • Gene Therapy, Rare, Orphan Disease • Oncology • Product Development • Government Regulations • IPO • Deal Structuring • Due Diligence • Complement-Mediated Disorders • Lysosomal Storage Disorders • Hemophilia • Metabolic Disorders • Neuromuscular Diseases • Cholestatic Liver Diseases • Pricing • P&L, Budget • Market Research • Performance Turnaround • Process Improvement • Diversity, Inclusion • Operations • Clinical, Medical Affairs • Organization Design • Problem Solving • Alliance Management • Biotechnology • Spanish, Portuguese Languages.
Listed skills include Pharmaceutical Industry, Product Launch, Biotechnology, Global Marketing, and 22 others.
Marcelo Cheresky, Mba's current company
Company context helps verify the profile and gives searchers a useful next step.
Marcelo Cheresky, Mba work experience
A career timeline built from the work history available for this profile.
Independent Consultant
Current
Chief Commercial Officer (Cco)
- Advised CEO and executives on developed & developing markets strategy, revenue, products, and services as senior leader that drove the company portfolio and geographical prioritization.
- Oversaw global rare diseases and gene therapy early development to commercial stage go-to-market planning, marketing, sales, contracts, negotiations, P&L, finance, regulatory, access, research partners, forecasts.
- Established a rare diseases business model with KPIs and processes, which produced a 34% yearly revenue growth in 2023.
- Recruited, trained, evaluated, and developed four general managers in China, Taiwan, Hong Kong, and Latin America and consultants in the USA and Europe.
- Discover untapped opportunities and alliances by researching markets, competitors, and internal company data.
Chief Business Officer, Global & China
- Supervise business development, alliances, contract, evaluation, diligence, negotiation, and execution for licensing and research collaboration agreements and commercial operations.
- Bought license rights from 7 companies to develop and commercialize rare disease, gene therapy, and oncology products.
- Delivered profitable revenue 28% over budget during the initial year of launch in Taiwan and Hong Kong.
- Led executive presentations to investors, banks, clients, and partners to prepare for IPO on the Hong Kong Stock Exchange.
Senior Vice President Commercial Operations, Ex-China
- Created rare disease and gene therapy strategies and implemented them in Taiwan, Hong Kong, and other markets.
- Led prioritization of geographies, diseases, and platforms in preparation for the IPO prospectus.
Vice President Emerging Markets
- Oversaw go-to-market strategy, P&L, regulatory, and price in Brazil, Colombia, Argentina, Australia, Taiwan, and Korea.
- Developed annual and long-term sales acquisition, account retention, revenue, profit, and market growth goals.
- Delivered $28M in sales, created structure for four country legal entities, and recruited, onboarded, and led employees.
Director Of Market Access
- Removed patient access barriers to treatment while following protocols, regulatory policies, and best practices.
- Increased infusion center training, connected more patients to physicians, and resolved insurance payor issues.
Vice President, Latin America
- Supervised Brazil, Mexico, Argentina, and Colombia planning, sales, marketing, P&L, patents, regulations, and operations.
- Advanced diagnostic with laboratories, centers of excellence, and treating physicians to magnify patient identification.
- Hired, onboarded, reviewed, and mentored a high-impact team of 30 staff in four country offices.
- Obtained 10%+ of globally recruited patients for Kanuma phase III trial and received regulatory approval in Mexico.
Regional Vice President Liaison – Asia Pacific & Latin America
- Directed and aligned go-direct strategy, sales, marketing, proposals, budget, regulatory, access, and operational structure.
- Created long-term plan and budget to maximize ROI by taking the product license back in three countries.
General Manager - Mexico
- Headed planning, sales, marketing, budget, regulatory, operations, and all other business functions in Mexico.
- Grew 2009 revenue 55%+ and 2010 57%+ by negotiating a large government contract and focusing on the public market.
- Recruited, trained, evaluated, and developed a top-performing team of 126 and directly led multi-disciplined staff.
Senior Marketing Director - Latin America
- Led rare disease marketing, product launches, $280M P&L revenue, and four staff.
- Earned product reimbursements in Mexico, Brazil, and Colombia by pioneering pharmacoeconomic models.
Global Marketing Director - Endocrinology
- Managed global strategy and marketing for Thyrogen product launch in Mexico, the Philippines, and Colombia.
- Delivered incremental $2.4 revenue (21% increase) by closing business opportunities in existing and new markets.
Senior Global Product Manager – Endocrinology
- Spearheaded Thyrogen launch in Latin America, Asia, Canada, and Australia, resulting in 52%+ revenue growth.
- Conducted rigorous market research to prepare for launch in Mexico, the Philippines, and Colombia.
Pharmaceutical Sales
Sales Supervisor, Primary Care DrugsGlobal Marketing Associate, Men’s HealthMarket Research Analyst, Men’s Health
Marcelo Cheresky, Mba education
Master Of Business Administration - Mba, Business Administration And Management, General
Bachelor Of Science - Bs, Marketing/Marketing Management, General
Frequently asked questions about Marcelo Cheresky, Mba
Quick answers generated from the profile data available on this page.
What company does Marcelo Cheresky, Mba work for?
Marcelo Cheresky, Mba works for KiteGene.
What is Marcelo Cheresky, Mba's role at KiteGene?
Marcelo Cheresky, Mba is listed as Chief Executive Officer at KiteGene.
What is Marcelo Cheresky, Mba's email address?
AeroLeads has found 2 work email signals at @canbridgepharma.com for Marcelo Cheresky, Mba at KiteGene.
What is Marcelo Cheresky, Mba's phone number?
AeroLeads has found 2 phone signal(s) with area code 617 for Marcelo Cheresky, Mba at KiteGene.
Where is Marcelo Cheresky, Mba based?
Marcelo Cheresky, Mba is based in Greater Boston, United States, United States while working with KiteGene.
What companies has Marcelo Cheresky, Mba worked for?
Marcelo Cheresky, Mba has worked for Kitegene, Self Employed, Canbridge Pharmaceuticals Inc., Bioverativ, A Sanofi Company, and Ultragenyx.
How can I contact Marcelo Cheresky, Mba?
You can use AeroLeads to view verified contact signals for Marcelo Cheresky, Mba at KiteGene, including work email, phone, and LinkedIn data when available.
What schools did Marcelo Cheresky, Mba attend?
Marcelo Cheresky, Mba holds Master Of Business Administration - Mba, Business Administration And Management, General from University Of North Carolina At Chapel Hill.
What skills is Marcelo Cheresky, Mba known for?
Marcelo Cheresky, Mba is listed with skills including Pharmaceutical Industry, Product Launch, Biotechnology, Global Marketing, Market Access, Biopharmaceuticals, Oncology, and Clinical Development.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial